The University of Iowa

Baseline Results of the NeuroNEXT Spinal Muscular Atrophy Infant Biomarker Study

Kolb SJ, Coffey CS, Yankey JW, Krosschell K, Arnold WD, Rutkove SB, Swoboda KJ, Reyna SP, Sankoju A, Darras BT, Shell R, Kuntz N, Castro D, Iannaccone ST, Parsons J, Connolly AM, Chiriboga CA, McDonald C, Burnette WB, Werner K, Thangarajh M, Shieh PB, Finanger E, Cudkowicz ME, McGovern MM, McNeil DE, Finkel R, Kaye E, Kingsley A, Renusch SR, McGovern VL, Wang X, Zaworkski PG, Prior TW, Burghes AHM, Bartlett A, Kissell JT & the NeuroNEXT Clinical Trial Network on behalf of the NN101 SMA Biomarker Investigators
Annals of Clinical and Translational Neurology. 2016; 3 (2) 132-145.
PubMed: 
Projects: